Replies to post #799302 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

"Your logic has a screw loose."

Ps you have not been able to post a coherent contribution here for ages Senti.

[dennisdave]

Your posts on this topic are appearing more and more flailing by the minute.

Is that right well why dont you tell the MHRA that


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177081083

Dear
Thank you for your email.
We generally require that the commercial manufacturing process intended for the MA be fully qualified, GMP- compliant, and reflected in the Manufacturers License before the MA is granted.
MHRA will typically assess the updated process as opposed to the original, especially if the applicant intends to commercialise the new route.
Timeline impacts are usually considered clock-stops, not backlog.
We generally cannot grant an MA based solely on the original process if the applicant no longer intends to use it.
The MA must reflect the commercial manufacturing route.
Kind regards,

Aleena
MHRA Customer Experience Centre
Communications and engagement team
10 South Colonnade, Canary W